Drug Type Shared antigen vaccine |
Synonyms- |
Target |
Mechanism MAGEA3 inhibitors(Melanoma-associated antigen 3 inhibitors), MAGEC1 antagonists(MAGE family member C1 antagonists), WT1 inhibitors(Wilms' Tumour 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Phase 1 | US | 31 Jan 2014 |